Similar Articles

The Metabolic Syndrome: A Cancer Risk Factor?

Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş

DOI: 10.5606/jebms.2023.1040

Issue: 2023, Volume 4 - Issue 1
571 535

Emerging Immunotherapeutic Approaches for Managing Metastasis

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2023.1050

Issue: 2023, Volume 4 - Issue 2
495 449

Nasopharyngeal Carcinoma: Causes and Incidence

Fatih Özgür Sarıbıyık, Oytun Erbaş

DOI: 10.5606/jebms.2023.1060

Issue: 2023, Volume 4 - Issue 3
426 318

Regulatory T Cells and Their Implications in Cancer Immunotherapy

Saime Sıla Gemici, Oytun Erbaş

DOI: 10.5606/jebms.2023.1064

Issue: 2023, Volume 4 - Issue 3
322 347

Cancer Stem Cells

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2024.1083

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
369 278

Stem Cell Therapy in Cancer

Ayça Nur Demir, Oytun Erbaş

DOI: 10.5606/jebms.2024.1084

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
311 283

Enteral Nutrition in Cancer Patients

Gamze Nur Yüksel, Oytun Erbaş

DOI: 10.5606/jebms.2024.1089

Issue: 2024, Volume 5 - Issue 2
229 397

Coffee Intake and Cancer Risk: Exploring the Relationship

Zehra Betül Aydın, Oytun Erbaş

DOI: 10.5606/jebms.2024.1091

Issue: 2024, Volume 5 - Issue 2
235 384

Aspirin and NSAIDs as Cancer Preventive Agents: A Review

Nadin Bedikyan, Oytun Erbaş

DOI: 10.5606/jebms.2024.1093

Issue: 2024, Volume 5 - Issue 2
248 398